Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary Embolism
Sabine Eichinger(Medical University of Vienna), Paul A. Kyrle(Karl Landsteiner Society), Georg Heinze(Medical University of Vienna), Lisanne M. Jandeck(Karl Landsteiner Society)
Cited by 502
Related Papers
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.2k
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
|New England Journal of Medicine|2021|2.3k
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
|New England Journal of Medicine|1998|1.7k
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2000|764
Deep vein thrombosis
|The Lancet|2005|620